Stigma and the non-communicable disease syndemic in aging HIV positive and HIV negative MSM

艾滋病毒阳性和艾滋病毒阴性男男性行为者中的耻辱感和非传染性疾病综合症

基本信息

项目摘要

ABSTRACT Over the next decade, more than 70% of people living with HIV (PWH) will be older than 50. The increasing burden of the non-communicable diseases (NCDs) hypertension, diabetes, and dyslipidemia has al-ready begun to present key challenges to effective HIV care among aging PLWH, including sexual minority men (SMM). Because these NCDs often present together as comorbid conditions, interact with each other adversely, and are inflected by social and structural inequities, they may comprise a synergistic epidemic (syndemic). In the U.S., there are substantial racial, ethnic, and socioeconomic disparities in the prevalence and/or control of NCDs and HIV. Intersecting stigmas, such as racism, classism, and homophobia, may drive these health disparities through direct and indirect mechanisms. Directly, intersectional stigma in healthcare settings may contribute to healthcare avoidance, decreasing success rates along HIV and NCD syndemic continua of care domains of retention, treatment, adherence, and disease control. Indirectly, experiencing intersectional stigma may lead to a psychosocial syndemic of stress, depression, violence, and substance use, thereby contributing to HIV and NCD incidence, prevalence, and poorer disease control. Very few if any studies have prospectively assessed the contribution of intersectional stigma to social disparities in NCD syndemic incidence, prevalence, and control among PWH; and few if any studies have rigorously assessed how the psychosocial syndemic may mediate pathways between social position and syndemic NCD and HIV outcomes. Collecting data over a four-year period, we will utilize the MACS/WIHS Combined Cohort Study, the longest-running cohort study of HIV+ and HIV- SMM in the U.S., to assess the following specific aims: 1) assess relationships between social position, intersectional stigma, and the psychosocial syndemic among middle-aged and aging HIV+ and HIV- SMM; 2) assess relationships between social position and NCD syndemic incidence and prevalence; and 3) assess relationships between social position and HIV and NCD syndemic continua of care outcomes, mediated by intersectional stigma and the psychosocial syndemic. Our scientific premise is that multiply marginalized populations experience disparities in NCD syndemic incidence, prevalence, and control, which are mediated by intersectional stigma and the psychosocial syndemic. The proposed work will extend intersectional stigma and psychosocial syndemics research on the HIV continuum of care to the NCD syndemic continuum of care. This proposal aligns with NIH high priority AIDS research areas outlined in NOT-OD-15-137 (“addressing the impact of HIV-associated comorbidities”) and with NHLBI RFA-HL-21-018, which calls for multifactorial research using syndemics frameworks to characterize clustering of heart, lung, blood, and sleep conditions within PWH. This study will provide critical data for informing the development of integrated, multilevel interventions intended to remediate disparities in NCD incidence, prevalence, and control among middle-aged and aging SMM, particularly SMM of color and PWH.
摘要 在接下来的十年里,超过70%的艾滋病毒携带者(PWH)将超过50岁。不断增长的 非传染性疾病(NCDs)、高血压、糖尿病和血脂异常的负担已经显现 开始对包括性少数男性在内的老年妇女保健中心的艾滋病毒有效护理提出重大挑战 (SMM)。因为这些非传染性疾病经常以共病状态出现,彼此相互作用 不利,并受到社会和结构性不平等的影响,它们可能构成一种协同作用的流行病 (Syndemic)。在美国,存在着巨大的种族、民族和社会经济差距 非传染性疾病和艾滋病毒的流行和/或控制。相互交叉的污名,如种族主义、分类主义和 同性恋恐惧症,可能通过直接和间接机制推动这些健康差距。直接, 医疗保健环境中的跨部门污名可能会导致医疗回避,降低成功率 保留、治疗、依从性、依从性和 疾病控制。间接地,经历跨部门的耻辱可能会导致压力的心理社会综合征, 抑郁、暴力和药物使用,从而导致艾滋病毒和非传染性疾病的发病率、流行率和 更差的疾病控制。很少有研究,如果有的话,前瞻性地评估 对非传染性疾病发病率、患病率和控制率的社会差异的跨界别污名 几乎没有任何研究严格评估了心理社会综合征如何可能起到中介作用 社会地位与非传染性疾病和艾滋病毒结果之间的路径。在四年内收集数据 期间,我们将利用MACS/WIHS联合队列研究,这是运行时间最长的HIV+队列研究 和美国的艾滋病毒-SMM,以评估以下具体目标:1)评估社会之间的关系 中老年HIV阳性和老年患者的位置、交叉耻辱和心理社会症状 HIV-SMM;2)评估社会地位与非传染性疾病发病率和 流行率;以及3)评估社会地位与HIV和NCD之间的关系 护理结果,由跨部门污名和心理社会综合征调节。我们的科学前提是 倍增的边缘化人群在非传染性疾病的发病率、患病率和 控制,这是由跨部门污名和心理社会综合征调节的。拟议中的工作 将把关于艾滋病毒连续护理的跨部门污名和心理社会综合体研究扩展到 非传染性疾病共同护理的连续体。这项建议与美国国立卫生研究院重点艾滋病研究领域相一致。 NOT-OD-15-137(“应对艾滋病毒相关共病的影响”)和NHLBI RFA-HL-21-018, 它要求使用综合框架进行多因素研究,以表征心脏聚集, 威尔斯亲王医院内的肺部、血液和睡眠状况。这项研究将提供关键数据,以告知 制定旨在纠正非传染性疾病发病率差异的综合、多层次干预措施, 中老年SMM的患病率和控制情况,特别是有色性和PWH的SMM。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mackey R Friedman其他文献

Mackey R Friedman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mackey R Friedman', 18)}}的其他基金

Stigma and the non-communicable disease syndemic in aging HIV positive and HIV negative MSM
艾滋病毒阳性和艾滋病毒阴性男男性行为者中的耻辱感和非传染性疾病综合症
  • 批准号:
    10757524
  • 财政年份:
    2023
  • 资助金额:
    $ 71.79万
  • 项目类别:
Stigma and the non-communicable disease syndemic in aging HIV positive and HIV negative MSM
艾滋病毒阳性和艾滋病毒阴性男男性行为者中的耻辱感和非传染性疾病综合症
  • 批准号:
    10672295
  • 财政年份:
    2023
  • 资助金额:
    $ 71.79万
  • 项目类别:
COVID-19 and the MWCCS: Psychosocial and Structural Impact on Physical and Mental Health, and HIV Prevention Behaviors
COVID-19 和 MWCCS:对身心健康以及 HIV 预防行为的社会心理和结构影响
  • 批准号:
    10217711
  • 财政年份:
    2019
  • 资助金额:
    $ 71.79万
  • 项目类别:
Innovation Fund Application to the MACS/WIHS Combined Cohort Study (MWCCS): COVID-19 Vaccine Acceptance and Hesitancy (CVHB) Study in People with HIV
MACS/WIHS 联合队列研究 (MWCCS) 创新基金申请:HIV 感染者的 COVID-19 疫苗接受和犹豫 (CVHB) 研究
  • 批准号:
    10390602
  • 财政年份:
    2019
  • 资助金额:
    $ 71.79万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 71.79万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.79万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 71.79万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.79万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 71.79万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.79万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 71.79万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 71.79万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 71.79万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.79万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了